Cited 0 times in Scipus Cited Count

Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer

DC Field Value Language
dc.contributor.authorYim, HE-
dc.contributor.authorKim, JH-
dc.contributor.authorAhn, MS-
dc.contributor.authorJung, Y-
dc.contributor.authorRoh, J-
dc.contributor.authorPark, SH-
dc.contributor.authorKim, TG-
dc.contributor.authorChoi, JH-
dc.contributor.authorKang, SY-
dc.date.accessioned2022-12-26T00:39:01Z-
dc.date.available2022-12-26T00:39:01Z-
dc.date.issued2021-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/23436-
dc.description.abstractPure mucinous breast carcinoma (PMBC) is characterized by clusters of tumor cells floating in abundant extracellular mucin and can be classified into paucicellular (Type A) and hypercellular (Type B) subtypes. However, the clinicopathological and genomic differences between these two subtypes have not been well characterized. We retrospectively investigated the clinicopathologic features of 45 cases of surgically removed PMBC (31 Type A and 14 Type B). We also performed whole-exome sequencing (WES) in eight cases of PMBC. We found that Type B PMBC occurs at an older age and shows more aggressive clinical behavior than Type A. WES analysis revealed that HYDIN was the most frequently mutated gene in both types of PMBC. Although Type B PMBC showed a tendency toward more frequent genetic alterations, there were no statistically significant differences between the two subtypes in single nucleotide variants or insertions or deletions of bases associated with moderate or high effects. Our results provide additional evidence that PMBCs are clinicopathologically and genetically heterogeneous and lack pathognomonic genetic alterations. Further, Type B PMBC is more frequently associated with lymph node metastasis than Type A.-
dc.language.isoen-
dc.titleClinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer-
dc.typeArticle-
dc.identifier.pmid33732635-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956951/-
dc.subject.keywordbreast cancer-
dc.subject.keywordhistological type-
dc.subject.keywordImmunohistochemistry-
dc.subject.keywordmucinous carcinoma-
dc.subject.keywordwhole-exome sequencing-
dc.contributor.affiliatedAuthorYim, HE-
dc.contributor.affiliatedAuthorKim, JH-
dc.contributor.affiliatedAuthorAhn, MS-
dc.contributor.affiliatedAuthorJung, Y-
dc.contributor.affiliatedAuthorRoh, J-
dc.contributor.affiliatedAuthorKim, TG-
dc.contributor.affiliatedAuthorChoi, JH-
dc.contributor.affiliatedAuthorKang, SY-
dc.type.localJournal Papers-
dc.identifier.doi10.3389/fonc.2020.558760-
dc.citation.titleFrontiers in oncology-
dc.citation.volume10-
dc.citation.date2021-
dc.citation.startPage558760-
dc.citation.endPage558760-
dc.identifier.bibliographicCitationFrontiers in oncology, 10. : 558760-558760, 2021-
dc.identifier.eissn2234-943X-
dc.relation.journalidJ02234943X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Files in This Item:
33732635.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse